Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report

1. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report
1. 1.1 Study Objectives
2. 1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Overview
3. 1.3 Reason to Read This Report
4. 1.4 Methodology and Forecast Analysis
2. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report - Preface
1. 2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report – Detailed Scope and Definitions
1. 2.1.1 By Service Type
2. 2.1.2 By Drug Type
3. 2.1.3 By End-user
4. 2.1.4 By Region
3. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics
1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
2. 3.2. Restraints – By Service Type, By Drug Type, By End-user, By Country
3. 3.3. Opportunities – By Service Type, By Drug Type, By End-user, By Country
4. 3.4. Trends – By Service Type, By Drug Type, By End-user, By Country
5. 3.5. PEST Analysis
6. 3.6. Porters Five Rule Analysis
7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
8. 3.8. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report – DROTs Impact Analysis
4. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Service Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 5.1 Drug Development
1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 5.2 Manufacturing
1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 5.3 Packaging
1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 5.4 Analytical Testing
1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 5.5 Others
1. 5.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 5.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 5.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 5.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
6. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Drug Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 6.1 Small Molecule
1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 6.2 Biologics
1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 6.3 Biosimilars
1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 6.4 Others
1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
7. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
1. 7.1 Pharmaceutical Companies
1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 7.2 Biotech Companies
1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 7.3 Others.
1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
1. 8.1 North America
   1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
2. 8.2 Europe
   1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
3. 8.3 Asia-Pacific
   1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
4. 8.4 Latin America
   1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
5. 8.5 Middle East & Africa
   1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
   2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
   3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
   4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service Type, By Drug Type, By End-user, and Region, 2024 - 2031
9. North America Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Service Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.1.1 Drug Development
2. 9.1.2 Manufacturing
3. 9.1.3 Packaging
4. 9.1.4 Analytical Testing
5. 9.1.5 Others
9.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.2.1 Small Molecule
2. 9.2.2 Biologics
3. 9.2.3 Biosimilars
4. 9.2.4 Others
9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.3.1 Pharmaceutical Companies
2. 9.3.2 Biotech Companies
3. 9.3.3 Others.
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 9.4.1 United States
2. 9.4.2 Canada
9.5 North America Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service Type, By Drug Type, By End-user, and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 North America Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report - Company Profiles
1. 9.7.1 Company 1 (United States)
2. 9.7.2 Company 2 (Canada)
3. 9.7.3 Company 3 (Canada)
10. Europe Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
10.1 By Service Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.1.1 Drug Development
2. 10.1.2 Manufacturing
3. 10.1.3 Packaging
4. 10.1.4 Analytical Testing
5. 10.1.5 Others
10.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.2.1 Small Molecule
2. 10.2.2 Biologics
3. 10.2.3 Biosimilars
4. 10.2.4 Others
10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.3.1 Pharmaceutical Companies
2. 10.3.2 Biotech Companies
3. 10.3.3 Others.
10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 10.4.1 Germany
2. 10.4.2 United Kingdom
3. 10.4.3 France
4. 10.4.4 Spain
5. 10.4.5 Italy
6. 10.4.6 Russia
7. 10.4.7 Netherlands
8. 10.4.8 Poland
9. 10.4.9 Rest of Europe
10.5 Europe Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service Type, By Drug Type, By End-user, and Country, 2024 - 2031
10.6 Regional Trends Analysis
10.7 Europe Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report - Company Profiles
1. 10.7.1 Company 1 (Germany)
2. 10.7.2 Company 2 (United Kingdom)
3. 10.7.3 Company 3 (United Kingdom)
11. Asia-Pacific Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
11.1 By Service Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.1.1 Drug Development
2. 11.1.2 Manufacturing
3. 11.1.3 Packaging
4. 11.1.4 Analytical Testing
5. 11.1.5 Others
11.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.2.1 Small Molecule
2. 11.2.2 Biologics
3. 11.2.3 Biosimilars
4. 11.2.4 Others
11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.3.1 Pharmaceutical Companies
2. 11.3.2 Biotech Companies
3. 11.3.3 Others.
11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 11.4.1 China
2. 11.4.2 Japan
3. 11.4.3 India
4. 11.4.4 South Korea
5. 11.4.5 Australia & NZ
6. 11.4.6 ASEAN
7. 11.4.7 Rest of Asia-Pacific
11.5 Asia-Pacific Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service Type, By Drug Type, By End-user, and Country, 2024 - 2031
11.6 Regional Trends Analysis
11.7 Asia-Pacific Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report - Company Profiles
1. 11.7.1 Company 1 (China)
2. 11.7.2 Company 2 (Japan)
3. 11.7.3 Company 3 (Japan)
12. Latin America Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
12.1 By Service Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.1.1 Drug Development
2. 12.1.2 Manufacturing
3. 12.1.3 Packaging
4. 12.1.4 Analytical Testing
5. 12.1.5 Others
12.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.2.1 Small Molecule
2. 12.2.2 Biologics
3. 12.2.3 Biosimilars
4. 12.2.4 Others
12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.3.1 Pharmaceutical Companies
2. 12.3.2 Biotech Companies
3. 12.3.3 Others.
12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 12.4.1 Brazil
2. 12.4.2 Mexico
3. 12.4.3 Argentina
4. 12.4.4 Peru
5. 12.4.5 Colombia
6. 12.4.6 Rest of Latin America
12.5 Latin America Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service Type, By Drug Type, By End-user, and Country, 2024 - 2031
12.6 Regional Trends Analysis
12.7 Latin America Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report - Company Profiles
1. 12.7.1 Company 1 (Brazil)
2. 12.7.2 Company 2 (Mexico)
3. 12.7.3 Company 3 (Mexico)
13. Middle East & Africa Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
13.1 By Service Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.1.1 Drug Development
2. 13.1.2 Manufacturing
3. 13.1.3 Packaging
4. 13.1.4 Analytical Testing
5. 13.1.5 Others
13.2 By Drug Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.2.1 Small Molecule
2. 13.2.2 Biologics
3. 13.2.3 Biosimilars
4. 13.2.4 Others
13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.3.1 Pharmaceutical Companies
2. 13.3.2 Biotech Companies
3. 13.3.3 Others.
13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
1. 13.4.1 Saudi Arabia
2. 13.4.2 UAE
3. 13.4.3 South Africa
4. 13.4.4 Egypt
5. 13.4.5 Israel
6. 13.4.6 Rest of Middle East and Africa
13.5 Middle East & Africa Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market – Opportunity Analysis Index, By Service Type, By Drug Type, By End-user, and Country, 2024 - 2031
13.6 Regional Trends Analysis
13.7 Middle East & Africa Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report - Company Profiles
1. 13.7.1 Company 1 (Saudi Arabia)
2. 13.7.2 Company 2 (UAE)
3. 13.7.3 Company 3 (UAE)
14. Competition Landscape
14.1 Strategic Dashboard of Top Market Players
14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)

1. 14.2.1 Lonza Group Ltd.
2. 14.2.2 Catalent
3. 14.2.3 Inc.
4. 14.2.4 Recipharm AB
5. 14.2.5 Siegfried Holding AG
6. 14.2.6 WuXi AppTec Co.
7. 14.2.7 Ltd.
15. Data Collection Method and Research Approach
16. Principal Presumptions and Acronyms